Source: Studiocanal

Anna Marsh

Anna Marsh has been appointed CEO of Paris-based, pan-European film and television company Studiocanal, replacing Didier Lupfer who is leaving the company to pursue personal production projects.

In her new role, Marsh will be responsible for all Studiocanal operations in France and abroad. She will report to Maxime Saada, CEO of Canal+ Group and president of Studiocanal.

Marsh, who previously held the role of managing director of Studiocanal UK and EVP international sales, will take up her new position on December 16.  She will continue to run Studiocanal UK for an interim period until a new managing director is appointed.

“Anna is the ideal person to manage Studiocanal after being EVP distribution and then managing director of our UK subsidiary,” said Saada.

“Her in-depth knowledge of the company and our markets as well as her international profile will be essential to accelerate the development of Studiocanal in its ambition of becoming a leader in the production and distribution of European films and series.”

Saada also thanked Lupfer for his contribution to Studiocanal over the past four years. “Under the leadership of Didier, the company has taken on a new dimension, particularly in production, where he has been directly and successfully involved. We wish him every success in his projects.”

Anna Marsh has over 17 years of experience in the entertainment industry. After graduating from the University of Otago in New Zealand and then the international business school HEC in Paris, she began her career in 2002 in the international sales department of Tele Images Productions (Marathon group), before becoming international sales manager at TF1 International.

She joined Studiocanal in 2008 as VP international sales. In 2013, she was appointed head of international distribution strategy, and shortly after as head of international sales.

In 2017, she was appointed EVP, international distribution at Studiocanal and in March this year she was appointed managing director of Studiocanal in the UK.